Matthew W. Foehr
2011 - Ligand Pharmaceuticals
In 2011, Matthew W. Foehr earned a total compensation of $1.4M as Executive VP and Chief Operating Officer at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $123,959 |
|---|---|
| Option Awards | $869,814 |
| Salary | $247,950 |
| Stock Awards | $166,170 |
| Other | $2,643 |
| Total | $1,410,536 |
Foehr received $869.8K in option awards, accounting for 62% of the total pay in 2011.
Foehr also received $124K in non-equity incentive plan, $248K in salary, $166.2K in stock awards and $2.6K in other compensation.
Rankings
In 2011, Matthew W. Foehr's compensation ranked 4,443rd out of 10,747 executives tracked by ExecPay. In other words, Foehr earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,443 out of 10,747 | 59th |
Division Manufacturing | 1,580 out of 3,960 | 60th |
Major group Chemicals And Allied Products | 325 out of 1,038 | 69th |
Industry group Drugs | 196 out of 786 | 75th |
Industry Pharmaceutical Preparations | 153 out of 571 | 73rd |
Source: SEC filing on April 21, 2014.
Foehr's colleagues
We found three more compensation records of executives who worked with Matthew W. Foehr at Ligand Pharmaceuticals in 2011.